baber/WOPTO huggingface dataset:
Patent EA-003810-B1 (EA)
Title: Beverage dispensing and beverage containers
Inventor: BYRNE CHARLES MICHAEL
IPC: B65D85/73
Filed: 2000-11-03
Abstract: 1. A container having an openable closure and including a beverage selected from coffee and tea, wherein the beverage is non-carbonated and is saturated with an inert gas. 2. A container including a bulk beverage selected from coffee and tea, wherein the beverage is non-carbonated and is saturated with an inert gas. 3. A container according to claim 1 or claim 2, wherein the beverage also includes one or more additives selected from sweeteners, milk, milk substitute, cream, stabilizers, anti-oxidants, emulsifiers, alcohol, and flavorings. 4. A container according to any preceding claim, wherein the beverage also includes a foam-retaining agent. 5. A container according to claim 4, wherein the foam-retaining agent is polyglycol alginate or microcrystalline cellulose. 6. A container according to any preceding claim, which is a can or bottle having, as the closure, a removable part defined by a line of relative weakness and bearing a ring or other manually-engageable tab. 7. A container according to any preceding claim, which also includes an insert that gasifies the beverage or soft drink when the closure is opened. 8. A container according to any preceding claim, wherein the inert gas is nitrogen. 9. A container according to any preceding claim, wherein the beverage is coffee. 10. A container according to any preceding claim, wherein the beverage is unsweetened. 11. A container including a bulk beverage selected from coffee and tea, in association with means for dispensing the beverage, and means for introducing an inert gas on dispensing. 12. A container according to claim 11, wherein the beverage also includes one or more additives selected from sweeteners, milk, milk substitute, cream, stabilizers, anti-oxidants, emulsifiers, alcohol, and flavorings. 13. A container having an openable closure and including a soft drink saturated with an inert gas and including a foam-retaining agent in an amount sufficient to cause lathering on opening the container. 14. A bulk container including a soft drink and a foam-retaining agent, in association with means for dispensing the soft drink, and means for introducing an inert gas on dispensing. 15. A bulk container including a soft drink, saturated with an inert gas, and a foam-retaining agent. 16. A container according to any of claims 13 to 15, wherein the soft drink also includes one or more of sweeteners, stabilizers, anti-oxidants, emulsifiers, alcohol and flavorings. 17. A container according to any of claims 13 to 16, wherein the soft drink is a soda, lemonade, cola, ginger beer or root beer.
Patent EA-005922-B1 (EA)
Title: A process for the preparation of iopamidol and the new intermediates therein
Inventor: ANELLI PIER LUCIO
IPC: C07C237/46
Filed: 2001-11-29
Abstract: A process for the preparation of (S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzendicarboxamide (iopamidol) starting from 5-amino-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide (II) which process comprises a) reacting the compound of formula (II) with a suitable protecting agent, to give a compound of formula (III) wherein R is a group of formula A or B wherein R1 is a hydrogen atom, a C1-C4 straight or branched alkoxy group, R2 is hydrogen, a C1-C4 straight or branched alkoxy group and R3 is a C1-C4 straight or branched alkyl group, a trifluoromethyl or a trichloromethyl group; b) acylating the amino group in position 5 of the intermediate compound of formula (III), by reaction with a (S)-2-(acetyloxy)propanoyl chloride to give a compound of formula (IV) wherein R is as defined above; and c) removing all the acyl groups present in the compound of formula (IV) under basic conditions, with prior cleavage of the cyclic protections of the hydroxy groups in the carboxamido substituents under acidic conditions, when R is a group of formula A carboxamido hydroxy groups under acidic conditions. The invention also refers to the new intermediates of formula (III) and (IV) wherein -R is a group A.
Patent EA-007956-B1 (EA)
Title: Method for preparing medical formulation based on naphthalane oil
Inventor: MUSAEV ALISHIR VEIS OGLY
IPC: A61K9/06
Filed: 2003-11-05
Abstract: The invention relates to medicine, in particular, to pharmaceutics and can be applied, for example, in the treatment of musculoskeletal system.The inventive aim is to provide a method for preparing a highly-active medical formulation based on naphthalane having high consumer properties as an ointment resistant to stratification in long-term storage.The method provides preparing a medical formulation comprising a tar-free naphthalane, dimexide and lanoline, including agitating formulation ingredients with a definite sequence and cyclic recurrence.
Patent EA-014534-B1 (EA)
Title: Method of quantitative determination of 24s methylbrassinosteroids (brassinolide and castasterone) and a composition for its application
Inventor: KHRIPACH VLADIMIR ALEXANDROVICH
IPC: G01N33/53
Filed: 2007-06-01
Abstract: The invention relates to immunochemical assay, namely to the quantitative determination method of phytohormones, 24S-methylbrassinosteroids – castasterone and brassinolide, and can be used for detection of these brassinosteroids in water solutions, quantitative estimate in biological objects, residual wastes in soil, manufacturing water et al. The task of the present invention is the quantitative determination method of 24S-methylbrassinosteroids (castasterone and brassinolide) and composition for its realization which is distinguished as highly sensitive, environmental safety, simplicity, reliability and manufacturability. The problem is solved, firstly, by claimed method consisted in immunochemical detection of 24S-methylbrassinosteroids using polyclonal antibodies for castasterone; secondly, by composition for claimed method realization which includes: antibodies for castasterone immobilized on polymer plates; castasterone-horseradish peroxidase conjugate; buffer solution; chromogen–substrate buffer (solution of 3,3',5,5'-tetramethylbenzidine in substrate buffer with hydrogen peroxide); stop reagent – 4.8% solution of HSO.
Patent EA-010800-B1 (EA)
Title: Method for removing water from a wellbore fluid
Inventor: IVAN CATALIN
IPC: E21B37/08
Filed: 2007-01-09
Abstract: A method for removing water from a wellbore fluid is disclosed. The method may include the steps of contacting a wellbore fluid with a water absorbing polymer, where the wellbore fluid includes an aqueous fluid, allowing the water absorbing polymer to interact with the wellbore fluid for a sufficient period of time so that the water absorbing polymer absorbs at least a portion of water in the aqueous fluid, and separating the water absorbing polymer containing the absorbed water from the wellbore fluid.
Patent EA-011227-B1 (EA)
Title: Support frame for electrical apparatuses
Inventor: FABRIZI FABRIZIO
IPC: H01H9/18
Filed: 2006-04-03
Abstract: The present invention refers to a support frame (1) for wall mounting one or more electrical apparatuses, the frame comprising a frame body (2) that can be fixed to a wall and extending around an opening (5) defining a mounting seat suitable for receiving and holding one or more electrical apparatuses. The support frame (1) also includes at least one optical source (7.1, 7.2) suitable for generating an optical signal; an electrical circuit (20, 10) connected to said optical source (7.1, 7.2) to supply it with an electrical power supply signal; means (16.1, 16.2, 16.3) for housing said electrical circuit (20, 10) and said source (7.1, 7.2), made in said frame body (2). The frame body (2) allows the propagation of at least one part of said optical signal towards the outside of said body.
Patent EA-015947-B1 (EA)
Title: Fan blade of tower cooler
Inventor: DAVLETSHIN FELIKS MUBARAKOVICH
IPC: F04D29/38
Filed: 2009-07-20
Abstract: The invention relates to machinery construction, in particular, to design of fan blades for tower coolers and can be used, for example, in industrial heat engineering, in particular, in chemical, petrochemical and other enterprises, where cooling of reused water is required. A fan blade is embodied as a hollow casing and comprises a butt part representing a round stem and intended for fixing a blade to a bushing of a fan runner adapted to set the required operational angle of a blade, a body and a transitional part from the butt to its body, the latter is profiled and formed by an aerodynamic profile, having a chord of variable length L along a blade longitudinal axis, a rounded front edge, pointed or blunted rear edge arranged at chord's ends profile and connected therebetween by smooth lines of the upper and lower parts of the chord profile, in plan view the blade shape is embodied narrowing to the middle of the blade's body, and expanding from the middle to the blade end, the front and rear edges are concave to the blade longitudinal axis, wherein the transitional blade part is embodied stepped narrowing towards the blade butt end of the runner, the aerodynamic profile in normal section to the blade longitudinal axis has in the middle of the blade body a zone with profile maximum thickness equal 0.15-0.16 of chord L length in the given section and arranged at the distance from 0.37∙L to 0.38∙L measured from the profile front edge along its chord, said section is arranged at a Sdistance from the blade end, comprising from 0.40 to 0.42 of the S blade length, wherein the line of the aerodynamic contour upper part is convex towards the chord and the aerodynamic contour lower part is convex from the side of the front edge smoothly mating with concave surface from the side of the rear edge and crosses the chord behind the section with the profile maximum thickness in the direction from the front edge, wherein the profile maximum thickness decreases smoothly from the blade transitional part to the blade end from (0.22-0.24)L to (0.1-0.12)L and the angle of blade section at the blade end is set towards the rotation plane of the blade in the direction opposite to the angle of blade section setting at the baffle transitional part onset. The inventive result provides increase production output and stability of a tower cooler operation.
Patent EA-018918-B1 (EA)
Title: COMBINATION COMPRISING β-AGONIST AND PROGESTIN AND USE THEREOF IN THE TREATMENT OR PREVENTION OF MUSCLE LOSS
Inventor: GILBERT JULIAN CLIVE
IPC: A61K31/137
Filed: 2008-04-24
Abstract: The present invention provides a combination for the treatment or prevention of muscle loss comprising a β2-agonist and a progestin, as a combined preparation for separate, simultaneous or sequential administration. There is also proposed the use a combination of a β2-agonist and a progestin in the treatment or prevention of muscle loss and to method in the treatment or prevention of muscle loss according to a patient is administered a β2-agonist and a progestin separately in different dosage forms, simultaneously or sequentially in any order or together as combined dosage form.
Patent EA-018178-B1 (EA)
Title: Corrosion resistant steel for marine applications
Inventor: FAGOT ANNE
IPC: C21D8/02
Filed: 2008-12-18
Abstract: A steel, namely for marine applications, comprises by weight percent: carbon: 0.05 to 0.20; silicon: 0.15 to 0.55; manganese: 0.60 to 1.60; chromium: 0.75 to 1.50; aluminum: 0.40 to 0.80; niobium and/or vanadium: 0.01≤[Nb]+[V]≤0.60; sulphur: up to 0.045; and phosphorous: up to 0.045.
Patent EA-019529-B1 (EA)
Title: Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
Inventor: IZZO EMANUELA
IPC: A61K31/165
Filed: 2008-12-05
Abstract: The present invention relates to pharmacotherapy of a psychiatric disorder which is schizophrenia and/or anxiety wherein schizophrenia includes schizophrenia related disorder such as brief psychotic disorders, delusional disorders, schizoaffective disorders, and schizophreniform disorders, and anxiety includes panic disorders, obsessive-compulsive disorders (OCD), post-traumatic stress disorders (PTSD), social phobia or social anxiety disorders, specific phobia, and generalized anxiety disorders (GAD). The compounds of the invention are useful for the treatment of the above psychiatric disorders alone or in combination with other therapeutical agents effective in the treatment of schizophrenia and/or anxiety disorders.
Patent EA-022994-B1 (EA)
Title: Method for suppressing tolerance to an opioid-type analgesic
Inventor: OUCHI JUN
IPC: C07D495/04
Filed: 2009-05-29
Abstract: The present invention relates to a method for suppressing tolerance to an opioid-type analgesic, such as morphine, by administering an effective amount of a compound of formula (IIIB) or (IIIC)or a pharmaceutically acceptable salt thereof, as well as to the use of the compound (IIIB) or (IIIC) having an antagonistic activity on an adenosine Areceptor, or a pharmaceutically acceptable salt thereof for the manufacture of a suppressant of the opioid-type analgesic tolerance.
Patent EA-018371-B1 (EA)
Title: Aqueous flowable concentrate compositions of a microencapsulated dinitroaniline herbicide
Inventor: CANNAN TERRANCE M
IPC: A01N25/28
Filed: 2009-12-18
Abstract: The present invention relates to aqueous flowable concentrate compositions of a microencapsulated dinitroanline herbicide, in particular pendimethalin, which are flowable and have improved storage stability. The compositions contain: i. 50 to 400 g/l of a dinitroaniline herbicide in the form of microcapsules comprising a core material containing the dinitroaniline herbicide, in particular pendimethalin, and a polymeric wall material, the microcapsules being dispersed in an aqueous phase; ii. 100 to 500 g/l of a glyphosate salt which is dissolved in the aqueous phase and iii. at least one anionic surface-active substance.
Patent EA-019074-B1 (EA)
Title: Derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
Inventor: BARONI MARCO
IPC: A61P25/00
Filed: 2009-06-12
Abstract: The invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)-(bridged piperazinyl)-1-alkanone and ((phenyl)-2,5-dihydropyrrol-1-yl)-(bridged piperazinyl)-1-alkanone derivatives of the general formula (I) where A, B, m, W, n, and R5 are such as defined in Claim 1, to a method for preparing the same, and to the therapeutic application thereof.
Patent EA-020611-B1 (EA)
Title: Process for manufacturing tea product, tea product and health-improving composition
Inventor: COLLIVER STEVEN PETER
IPC: A23F3/18
Filed: 2009-09-30
Abstract: Disclosed is a process comprising the steps of expressing juice from a first supply of fresh tea leaves thereby to produce leaf residue and tea juice; subjecting the first supply of fresh tea leaves and/or the tea juice to a fermentation step thereby to at least partially ferment the tea juice; and combining the at least partially fermented tea juice with substantially unfermented tea material.
Patent EA-028590-B1 (EA)
Title: Met inhibitors for enhancing radiotherapy efficacy
Inventor: BOCCACCIO CARLA
IPC: C12N15/13
Filed: 2012-03-16
Abstract: Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients suffering from a cancer for reducing and/or abrogating patients' resistance to radiotherapy, wherein the Met inhibitor is selected among: i) an anti-Met monoclonal antibody, ii) a genetically engineered antibody containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, and iii) a fragment of (i) or (ii) containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, or combinations thereof.
Patent EA-023725-B1 (EA)
Title: Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
Inventor: WU TOM YAO-HSIANG
IPC: C07K5/04
Filed: 2011-03-23
Abstract: The invention provides a novel class of compounds of formula (I)immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 2. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine.
Patent EA-025120-B1 (EA)
Title: Iminothiadiazine dioxide derivatives as bace inhibitors, compositions based thereon, and their use
Inventor: SCOTT JACK D
IPC: A61K31/54
Filed: 2010-10-06
Abstract: The invention provides iminothiadiazine dioxide derivatives of the following formulae:including pharmaceutically acceptable salts of said compounds. The novel iminothiadiazine dioxide derivatives of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (Aβ) production. Pharmaceutical compositions comprising one or more such compounds and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.
Patent EA-030397-B1 (EA)
Title: Human antibodies to human tnf-like ligand 1a (tl1a)
Inventor: CLASSON BRENDAN J
IPC: C07K16/28
Filed: 2011-11-08
Abstract: The present invention provides isolated antibody or antigen-binding fragment thereof that specifically binds and neutralizes human TNF-like ligand 1A (hTL1A) activity. The present invention also provides an isolated nucleic acid encoding the antibody or antigen-binding fragment thereof, an expression vector comprising the nucleic acid, a method of producing an anti-hTL1A antibody or antigen-binding fragment thereof and a pharmaceutical composition. The human anti-hTL1A antibodies are useful in treating diseases or disorders associated with TL1A, such as ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, diabetes, asthma and allergic lung inflammation.
Patent EA-023203-B1 (EA)
Title: Process and apparatus for separation of gases
Inventor: UNGERANK MARKUS
IPC: C10L3/10
Filed: 2011-05-26
Abstract: The invention relates to a specific apparatus, more particularly a chain of gas separation membrane modules, for separation of gas mixtures into two fractions each of elevated purity, and to a process for separating a gas mixture with this apparatus.
Patent EA-029103-B1 (EA)
Title: Biological wound cover
Inventor: ABUGALIEV KABYLBEK RIZABEKOVICH
IPC: A61L15/32
Filed: 2014-09-05
Abstract: The invention relates to medicine, particularly medical biotechnology, and may be applied for producing biological wound covers of prolonged healing action due to silver particles included therein. Technical result is achieved by formation of biological wound cover based on natural material and containing silver, wherein the natural material is collagen-elastin matrix, obtained from bovine peritoneum after elimination of cells followed by impregnation of silver micro particles using a photochemical reaction; the said peritoneum is treated with 0.25, 0.5 or 1% silver nitrate solution and exposed to UV lighting for 10 min. Elimination of donor cells can significantly reduce immunogenicity of the implant, and also can reduce risk of post-implantation inflammation, necrobiosis, or any other degenerative process initiated by recipient's immune system. Impregnation of xenogenic peritoneum with silver can significantly increase sterility and antimicrobial action of the proposed cover. Silver particles are impregnated therein both on tissue surface, and amidst collagen filaments and fibres.
Patent EA-027824-B1 (EA)
Title: Ceramic material and method for production thereof
Inventor: SHEMYAKINA IRINA VLADIMIROVNA
IPC: C04B35/626
Filed: 2015-01-29
Abstract: The invention is related to the field of medicine and can be used for making implants and coupling pair elements of artificial joints, and in other industries where highly wear-resistant materials are required. The ceramic material consists of AlO/ZrOcomposition with micro-additives of YO, SrO, CrO. The components are introduced in the following ratio, wt.%: AlO- 73-75%; ZrO- 23-25%; micro additives - not more than 3%, where AlOis in α phase, ZrOis cleaned of anions, and micro additives are used in the form of complex salts. For obtaining the ceramic material, main powder components are mixed with deionized water. ZrOpowder mixed with water is preliminarily cleaned of anions on an ion-exchange material, and pH of the suspension produced is adjusted to 8.3-8.5 with 10% ammonia solution. A thinner is added, and then AlOin α phase is introduced slowly. The AlO/ZrOsuspension is transferred to a bead mill where mixing and grinding are continued. Then micro additives in the form of a prepared suspension of complex salts YCrO, SrZrOare added to the mixture, the micro additives being introduced slowly. Polyethylene glycol and polyvinyl alcohol are used as an organic binder. Maximum temperature during preparation of granulated powder must be not lower than 230°C. Before compression operation, the material is moistened to 1.5-2.0%.
Patent EA-027170-B1 (EA)
Title: Pharmaceutical composition for correcting symptoms of or treating asthenia and/or chronic fatigue syndrome
Inventor: MOROZOVA MARGARITA ALEKSEEVNA
IPC: A61P25/28
Filed: 2015-03-17
Abstract: The invention relates to the field of medicine, and more particularly to pharmacology, and even more particularly to pharmaceutical compositions for treating various conditions associated with a lack of energy potential resulting from a pathological process. A pharmaceutical composition for correcting symptoms of or treating asthenia and/or chronic fatigue syndrome, when isolated or combined with various diseases and/or premorbid and/or postmorbid conditions in mammals, is characterized in that it contains, as active ingredients, 2-ethylthiobenzimidazole hydrobromide and/or a pharmaceutically acceptable salt thereof, and levocarnitine in therapeutically effective amounts.
Patent EA-027330-B1 (EA)
Title: Washover mill
Inventor: ISMAILOV FAKHREDDIN SATTAR OGLY
IPC: E21B29/00
Filed: 2014-12-25
Abstract: The invention is related to oil and gas industry, in particular, to restoration by centering milling of faulted facilities in vertical, horizontal and inclined on-shore and off-shore wells. In a washover mill comprising a body with screw grooves made on its inner surface, an adaptor, and a cutting member on the bottom end skewed relative to the body axis, the body is provided with circular process recesses perpendicular to the grooves and deepened at crossings, support inserts of the cutting member material are mounted in the recesses, thin-walled support tubes semiopen inwards are fixedly mounted on the body in holes drilled along the body height, and the cutting member is provided on its bottom with a guide lip, the transition from inner surface of the lip to the outer surface being arcuate; outside diameter of the cutting member is greater than outside diameter of the body, and inside diameter of the cutting member is less than outside diameter of the body. The washover mill length, height, cutting member outside and inside diameters are determined, respectively, from the following relationships:where Lis length of the washover mill, mm; Dis outside diameter of the washover mill body, mm; Dis outside diameter of the cutting member, mm; Dis inside diameter of the production string, mm; His height of the cutting member, mm; Δ is a gap between the washover mill and the inner wall of the production string, mm; Ris minimum curvature radius of the well-bore trajectory, mm; dis inside diameter of the cutting member, mm; dis diameter of the faulty tube, mm; dis diameter of the faulty tube coupling, mm.